Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-039938

SVP, Chief Accounting Officer sold 379 shares at $9.45 ($3,582)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sabatini Brent SVP, Chief Accounting Officer 2026-06-01 Sale 10b5-1 −379 $9.45 $3,582 61,902 D
Open-market sales · 379 sh · avg $9.45 · $3,582
Loading xslF345X06/wk-form4_1780435911.xml…